UK markets closed

Panacos Pharmaceuticals, Inc. (PANC)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 03:18PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -100.18
52-week change 30.00%
S&P500 52-week change 322.38%
52-week high 30.0085
52-week low 30.0000
50-day moving average 30.0003
200-day moving average 30.0003

Share statistics

Avg vol (3-month) 3855
Avg vol (10-day) 328.91k
Shares outstanding 553.64M
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 10.00%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2007
Most-recent quarter (mrq)30 Sept 2008

Profitability

Profit margin 0.00%
Operating margin (ttm)-31,545.83%

Management effectiveness

Return on assets (ttm)-52.62%
Return on equity (ttm)-168.83%

Income statement

Revenue (ttm)99k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-20.00%
Gross profit (ttm)N/A
EBITDA -33.84M
Net income avi to common (ttm)-35.76M
Diluted EPS (ttm)-0.6670
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)26.89M
Total cash per share (mrq)0.5
Total debt (mrq)18.21M
Total debt/equity (mrq)345.33%
Current ratio (mrq)2.15
Book value per share (mrq)0.10

Cash flow statement

Operating cash flow (ttm)-31.15M
Levered free cash flow (ttm)-16.93M